The US Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Limited from entering the United States due to manufacturing violations.......
Pharmaceutical major Ranbaxy Labortaories on Wednesday said it remained confident that its products were safe and effective as the US Department of Justice (DoJ) withdrew a legal motion against it......
The Canadian health and drug regulator Health Canada has asked Ranbaxy Pharmaceuticals Canada (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL) to withdraw its generic, 25......
Ranbaxy, one of the first Indian companies to set up a venture in China in 1993, is bullish in its operations, securing increased market share for its innovative medicines and also for sourcing......
India's leading drug-maker Ranbaxy on Wednesday said it has acquired Terapia, the largest independent generic company in Romania, for $324 million and aims to make that country its manufacturing......